Skip to main content
. 2021 Mar 22;23(9):1559–1566. doi: 10.1093/ntr/ntab049

Table 1.

Baseline Characteristics by Age Group Category

Characteristic Age group
18–24 ≥25 Effect sizea (95% CI) p
N 87 1163
Treatment group, number (%) .21
 Gradual reduction 27 (31.0) 571 (40.5)
 Immediate reduction 41 (47.1) 462 (39.7)
 Control 19 (21.8) 230 (19.8)
Age in years, mean (SD) 21.9 (1.8) 46.8 (12.2)
Gender, number, % male 58 (66.7) 643 (55.3) .04
Race, number (%) <.01
 White 63 (72.4) 695 (59.8)
 Black 8 (9.2) 365 (31.4)
 Other 14 (16.1) 82 (7.1)
Cigarettes per day 14.8 ± 6.8 17.3 ± 8.6 0.3 (0.1, 0.5) <.01
FTND, mean (SD) 3.7 ± 1.7 4.3 ± 1.7 0.3 (0.1, 0.5) <.01
Psychological Reward at baseline, mean (SD) 3.6 ± 1.3 3.1 ± 1.4 −0.4 (−0.6, −0.2) <.01
Smoking Satisfaction at baseline, mean (SD) 4.8 ± 1.4 4.7 ± 1.4 −0.1 (−0.3, 0.1) .39
Enjoyment of Respiratory Tract Sensations at baseline, mean (SD) 4.1 ± 1.7 3.4 ± 1.7 −0.4 (−0.6, −0.2) <.01
Craving Reduction at baseline, mean (SD) 4.3 ± 1.9 4.5 ± 1.9 0.1 (−0.1, 0.4) .24
Aversion, mean (SD) 1.3 ± 0.5 1.3 ± 0.6 0.0 (−0.2, 0.2) .97
TNEs at baseline, geometric mean (range) 44.7 (3.7–148.4) 60.3 (0.2–492.7) 0.4 (0.2, 0.6)b <.01
Nicotine metabolite ratio at baseline, mean (SD) 0.4 ± 0.2 0.4 ± 0.2 0.1 (−0.1, 0.3) .42

p-Values represent t-tests of differences for continuous variables and chi-square tests for categorical variables. Subjective response scores were in reference to participants’ usual brand cigarettes at baseline. Bold values indicate significant p-value. p-value for TNEs is derived from a t-test comparing log-transformed TNE values. CI = confidence interval; FTND = Fagerström Test for Nicotine Dependence; TNE = total nicotine equivalents.

aEffect size = difference in means (older age group − younger age group) by pooled standard deviation.

bEffect size reported was on log transformed TNEs.